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Health-related quality of life and life satisfaction
in colorectal cancer survivors: trajectories of
adjustment
Jeff Dunn1,2,3†, Shu Kay Ng1†, William Breitbart4, Joanne Aitken1,2,5, Pip Youl1,2, Peter D Baade1,2,5
and Suzanne K Chambers1,2,6,7*†
Abstract
Background: This longitudinal study describes the five year trajectories of health-related quality of life (HR-QOL)
and life satisfaction in long term colorectal cancer survivors.
Patients and methods: A population-based sample of 1966 colorectal cancer survivors were surveyed at six time
points from five months to five years post-diagnosis. Predictor variables were: socio-demographic variables,
optimism; cancer threat appraisal; perceived social support. Quality of life was assessed with the Functional
Assessment of Cancer Therapy-Colorectal (HR-QOL); and the Satisfaction with Life Scale. Growth mixture models
were applied to identify trajectory classes and their predictors.
Results: Distinct adjustment trajectories were identified for HR-QOL and life satisfaction. Lower optimism, poorer
social support, a more negative cognitive appraisal, and younger age were associated with poorer life satisfaction,
while survivors with less than 8 years of education had higher life satisfaction. This pattern was similar for overall
HR-QOL except that educational level was not a significant predictor and later stage disease and female gender
emerged as related to poorer outcomes. One in five survivors reported poorer constant HR-QOL (19.2%) and a
small group had poor life satisfaction (7.2%); 26.2% reported constant high HR-QOL and 48.8% had high constant
life satisfaction. Socioeconomic disadvantage and remoteness of residence uniquely predicted poorer outcomes in
the colorectal cancer specific HR-QOL sub domain.
Conclusion: Although HR-QOL and subjective cognitive QOL share similar antecedents their trajectory patterns
suggested they are distinct adjustment outcomes; with life satisfaction emerging as temporally stable phenomenon.
Unique patterns of risk support suggest the need to account for heterogeneity in adjustment in longitudinal QOL
studies with cancer survivors.
Keywords: Longitudinal, Cancer, Survivorship, Quality of life, Colorectal
Background
With nearly three quarters of a million people diagnosed
in 2008, colorectal cancer is estimated to be the most com-
mon incident cancer in the developed world [1]. In 2008
there were an estimated 3.3 million people living with a
diagnosis of colorectal cancer within the previous 5 years
[1]. Although there has been a decrease in incidence rates
in Australia [2], as in the United States [3], the numbers of
people diagnosed with colorectal cancer (CRC) each year
continue to increase [2]. Despite having one of the highest
incidence rates in the world [1], survival outcomes for
Australians diagnosed with colorectal cancer are relatively
high compared to other countries [4]. Survival expectations
increase the longer they survive, so that CRC cancer pa-
tients who have survived seven years after diagnosis can
anticipate similar 5-year survival outcomes to the general
population [5]. The high prevalence of this disease brings
into sharp focus the issue of how colorectal cancer influ-
ences long term quality of life.
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A recent systematic review of quality of life (QOL) out-
comes for long term colorectal cancer survivors concluded
that long term QOL overall is good for these patients, but
noted that research to date was limited by being largely
cross sectional in design [6]. Predictors of poorer out-
comes included: younger age, lower income and a smaller
social network. A longitudinal study of CRC patients over
a ten year period found that CRC survivors reported stable
or improved QOL over the first three years from diagno-
sis, however from three to ten years function declined [7].
Younger age at diagnosis (<60 years) was found to be pre-
dictive of poorer QOL across role, social, emotional, and
cognitive functioning and on this basis it was concluded
that longitudinal development of QOL was dependent
upon age at diagnosis. Our team identified that baseline
QOL was a strong predictor of QOL five years after
treatment, with gender, private health insurance, social
support, and threat appraisal influencing various QOL do-
mains [8]. However, by comparison to the previous study
[7] no effect was found for age. Hence, there is still lack of
clarity about who is most at risk for poorer long term
outcomes.
In this regard, optimism presents as a dispositional
trait that influences both psychological and quality of life
outcomes after cancer [9-11]. Optimism is defined as
the generalized expectancy that more good things than
bad will happen in the future [12]. The effect of opti-
mism on outcomes appears to be mediated by threat
appraisal [13], such that more optimistic people form
more positive appraisals about the consequences of their
cancer, and the likely outcomes, and from this experi-
ence less distress compared to people who are more
pessimistic. Finally, social support is also an important
and well accepted antecedent of both psychological and
HR-QOL outcomes [9], such that the social environment
in which a person lives may help (if positive) or hinder
(if negative) the adjustment process.
In assessing QOL after cancer, two measurement ap-
proaches present: health-related quality of life and life
satisfaction. Health-related quality of life (HR-QOL) is a
multi-dimensional construct that incorporates, at mini-
mum. the social, psychological and physical aspects of
health [14]. On this view, these different aspects of HR-
QOL make up layers of well-being that influence a per-
son’s health status and that when disrupted by disease are
expressed as decrements in these domains of quality of
life. Accordingly, measurement approaches for HR-QOL
tend to be domain and symptom-based, matching these
layers. Over the past three decades a wealth of research,
on a global scale, has emerged seeking to accurately mea-
sure HR-QOL, some of which has developed more generic
approaches relevant to a person with any illness status
[15], and some if which is tied to a specific disease, such
as cancer and the various cancer types [16].
By contrast, life satisfaction is conceptualized as the out-
come of a person’s judgment about the extent to which
their current life quality matches their self-imposed life
standards [17]. Hence, by contrast to the quite specific
measurement approach used in HRQOL, assessment of
life satisfaction is more global and relates more to internal
individual standards that are likely, at least in part, disposi-
tional. As an example, one person may perceive that if
they were unable to function physically in a certain way
that their life would be intolerable, whereas another per-
son might view these functions as less crucial. The actual
physical changes may be the same, however the judgment
of what these changes mean differs, and hence so does the
person’s overall life satisfaction.
Our study assessed the five year trajectories of both HR-
QOL and life satisfaction in long term colorectal cancer
survivors’ adjustment using an analytic approach known
as growth mixture modelling [18]. Socio-demographic
variables as well as optimism, threat appraisal and social
support were included as predictor variables. In this ap-
proach we aimed to provide a more complete understand-
ing of the QOL implications of colorectal cancer, both
health-related and subjective, over time and more clearly
identify what subgroups of patients are at risk for poorer
outcomes.
Materials and methods
Participants and procedure
These data are from a longitudinal study of patients
diagnosed with colorectal cancer (CRC), the sample and
methods of which are described in detail elsewhere [19].
Ethical approval was provided by the University of
Queensland. All residents in Queensland, Australia with
a histologically confirmed diagnosis of a primary CRC
between January 1, 2003, and December 31, 2004 were
eligible. Eligibility criteria included speaking English; hav-
ing no hearing, speech or cognitive disabilities that would
prevent completing a telephone interview; and being aged
between 20 and 80 years at diagnosis. The treating doctors
of 3,626 eligible cases were approached in writing for per-
mission to contact their patients regarding the study. The
3,182 cases for whom doctor consent was obtained were
mailed a letter signed by their treating doctor explaining
the study, a study information sheet and consent form.
Those who did not respond were sent a second letter two
weeks later. Following this, non-responders received two
follow-up telephone calls to try and ascertain a response.
Age, sex, tumor site and stage of disease were collected
from pathology/medical records. Socio-demographic and
medical variables were assessed by computer-assisted tele-
phone interview at baseline; all other measures were by
mailed self-report survey at each assessment point.
In all, 1966 participants provided informed consent and
entered the study at 5-month after diagnosis (Time 1
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(T1)). Consenting patients completed a self-administered
questionnaire (SAQ) and computer assisted telephone
interview (CATI). Participants were subsequently followed-
up at 12 (T2), 24 (T3), 36 (T4), 48 (T5) and 60 months
(T6) post-diagnosis. Among the 1884 participants who
completed at least one SAQ, 450 participants (24%) had
died by five years post-diagnosis (T6). We report data for
these 1884 participants.
Predictor variables
Socio-demographic and medical variables, including sex,
age, education attainment, disease stage, cancer site, treat-
ment type, number of comorbidities, the Accessibility/
Remoteness Index of Australia (ARIA) [20], and the Index
of Relative Socioeconomic Disadvantage (IRSD) [21] clas-
sification were assessed at baseline.
The ARIA represents the remoteness of residence when
diagnosed with CRC and is based on road distance mea-
surements. The IRSD is an area-based measure of socio-
economic status (SES) and considers factors such as the
percentage of residents in each Statistical local areas (SLA:
used as the geographic definition for area) on a low in-
come, in unskilled occupations, and unemployed (among
others). Its quintile represents the increasing advantage
(Quintile 1, most disadvantaged).
Dispositional optimism was measured by the Revised
Life Orientation Test [22], a 10-item scale consisting of
six target items and four filler items. Items are scored on a
five point responses scale where participants are asked
to indicate their extent of agreement from 0 (strongly dis-
agree) to 4 (strongly agree). Higher scores indicate greater
optimism. Internal consistency for the current study was
very good (α = 0.71-0.77). Cancer threat appraisal was
measured by the Constructed Meaning Scale that assesses
participants’ appraisal of the effect that cancer has had on
their identity, relationship and perceived future. Partici-
pants indicate their agreement to eight items using a 4-
point scale from 1 (strongly disagree) to 4 (strongly agree).
Negatively worded items are reverse scored with response
summed where a lower overall score indicates a more
negative cognitive appraisal. Internal consistency for the
current study was very good (α = 0.78-0.82). Perceived so-
cial support was measured using the Brief Social Support
Questionnaire (SSQ-6) [23]. Participants rate how satisfied
they are with various aspects of social support on a 5-
point scale ranging from 1 (Very dissatisfied) to 5 (very
satisfied). The scale of the SSQ-6 demonstrates high in-
ternal reliability (α = .92-.93) [23].
Outcome variables
Satisfaction with life
The Satisfaction with Life Scale (SWLS) [24] was used to
assess participant’s subjective cognitive well-being. The
five item scale asks participants to indicate on 7-point
scale ranging from 1 (Strongly disagree) to 7 (Strongly
agree), with higher scores indicating a higher satisfaction
with life. The SWLS demonstrates high internal reliability
(α = .87) [24].
Health-related quality of life
Health-related quality of life was assessed using the
Functional Assessment of Cancer Therapy-Colorectal
(FACT-C) scale [16]. The FACT-C has 36 items in total
and includes 5 subscales: physical (GP); functional (GF);
social/family (GS); emotional well-being (GE) as well as
a colorectal cancer specific domain (GC). Participants
indicate how true the scale items have been for them in
the past seven days on a scale from 0 (Not at all) to 4
(Very much). The FACT-C demonstrates good internal
consistency (α = .85) [16].
Statistical analyses
Growth mixture models (GMMs) [18,25] were applied to
identify trajectory classes and predictors of membership in
these classes, separately for the SWLS and the FACT-C
scale and the FACT-C subscales. The GMMs are flexible
to model individual growth trajectories from unobserved
subpopulations (latent trajectory classes) with individual
variation in growth parameters (such as intercept and
slope) that are captured by random effects as continuous
latent variables [26,27]. Another advantage of this analyt-
ical approach is that predictors of membership in the
trajectory classes are identified within the GMM frame-
work [28]. It implies that the “net” effect from each pre-
dictor can be quantified with the adjustment for the other
predictors, and hence the unique characteristics for each
trajectory class can be identified.
The GMM analyses were performed using Mplus Ver-
sion 6.12 [28]. Non-linear GMMs (consisting of intercept,
slope and quadratic growth parameters) were considered,
where the within-class quadratic variance components
were fixed at zero to avoid convergence problems and im-
proper solutions [29]. Missing SWLS and FACT-C scores
were handled in Mplus using a robust full information
maximum likelihood (FIML) estimation procedure with
the assumption that the missing scores are unrelated to
the outcome variable; see Jung and Wickrama (2008) [29].
Estimates of covariance coverage for each pair of variables
were checked for evaluating the impact of missing data
on model convergence. Initial growth parameters were
obtained by implementing a latent class growth analysis
(assuming no within-class variance) fitted to the data. The
GMM analyses were implemented with 200 random sets
of starting values and 20 final optimizations. The number
of trajectory classes K was determined using the Lo-
Mendell-Rubin likelihood ratio test (LMR-LRT) statistic
[29,30]. Finally, covariates were entered into the K-class
(unconditional) GMM via multinomial logistic regression
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that compares the reference class (high SWLS or FACT-C
scores) with the other trajectory classes (lower SWLS or
FACT-C scores).
Results
Trajectory classes based on SWLS
Four distinct classes of trajectory patterns were identi-
fied for the SWLS using GMM (Figure 1). These classes
were named based on the overall shape of the five year
trajectory. The Constant High (CH) Satisfaction class in-
dicates a group of patients (48.8%) who had a constantly
high SWLS throughout the five years of follow-up
period. The Medium Decrease (MD) class represents a
group of patients (24.8%) whose SWLS rose gradually from
a medium start and then at 3 years post-diagnosis began
to decrease. The Medium Increase (MI) class (19.1% of
patients) indicates a SWLS trajectory pattern which de-
creased steadily from a medium level and then increased at
3 years post-diagnosis. The Constant Low (CL) Satisfaction
class represents a group of patients (7.2%) who had a con-
stantly low SWLS.
Five predictors that significantly (p < 0.05) differentiated
the SWLS trajectory classes with the Constant High (CH)
as the comparison class were identified within the GMMs
(Table 1). Compared to the Constant High (CH) class,
patients with poor social support (adjusted OR = 1.44,
95% CI = 1.1 – 1.8), a more negative cognitive appraisal
(adjusted OR = 1.14 per unit decrease in the appraisal
score, 95% CI = 1.1 – 1.2) and those with low optimism
(adjusted OR = 1.11 per unit decrease in the optimism
score, 95% CI = 1.1 – 1.2) had an elevated chance of mem-
bership in the Medium Decrease (MD) class. Again, in
comparison with the CH class, the Medium Increase (MI)
class was characterized by younger age (adjusted OR =
1.25, 95% CI = 1.0 – 1.6), poor social support (adjusted
OR = 1.62, 95% CI = 1.3 – 2.0), a more negative cognitive
appraisal (adjusted OR = 1.16 per unit decrease in the
appraisal score, 95% CI = 1.1 – 1.2) and low optimism
(adjusted OR = 1.19 per unit decrease in the optimism
score, 95% CI = 1.1 – 1.3), and less patients with less than
eight years education (adjusted OR = 0.37, 95% CI = 0.2 –
0.9). Finally, compared to the CH class, the Constant Low
(CL) Satisfaction class was differentiated by younger age
(adjusted OR = 2.01, 95% CI = 1.5 – 2.8), poor social sup-
port (adjusted OR = 1.89, 95% CI = 1.4 – 2.5), a more
negative cognitive appraisal (adjusted OR = 1.40 per unit
decrease in the appraisal score, 95% CI = 1.3 – 1.5) and
low optimism (adjusted OR = 1.31 per unit decrease in the
optimism score, 95% CI = 1.2 – 1.4).
Trajectory classes based on FACT-C scores
Four distinct classes of trajectory patterns for Quality of
Life FACT-C scores were identified using GMM (Figure 2).
The Constant High (CH) class indicates a group of
patients (26.2%) who had a constantly high FACT-C
throughout the five years of follow-up period. The Con-
stant Medium (CM) class represents the largest group of
patients (47.1%) whose FACT-C remained at a medium
level throughout the follow-up period. The Medium
Decrease (MD) class (7.4% of patients) indicates a FACT-
C trajectory pattern which decreased dramatically from a
medium level, especially after 2 years post-diagnosis. The
Constant Low (CL) class represents a group of patients
(19.2%) who had a constantly low FACT-C. Six predictors
that with the Constant High (CH) Quality of Life as the
comparison class significantly differentiated the trajectory
classes are presented in Table 2. Unlike the findings for
the SWLS Satisfaction scores in Table 1, education level
was not a risk factor for differentiating the Quality of Life
classes. However, we found that patients with poor social
support had a higher chance of belonging to the Constant
Medium (CM) class compared to the Constant High (CH)
class (adjusted OR = 1.42, 95% CI = 1.0 – 2.0). Other
significant predictors were negative cognitive appraisal
(adjusted OR = 1.27 per unit decrease in the appraisal
score, 95% CI = 1.2 – 1.4) and low optimism (adjusted
OR = 1.10 per unit decrease in the optimism score, 95%
CI = 1.0 – 1.2). Again compared to the Constant High
(CH), the Medium Decrease (MD) class was characterized
by patients with late disease stage (adjusted OR = 3.46,
95% CI = 1.7 – 7.1) and negative cognitive appraisal
(adjusted OR = 1.24 per unit decrease in the appraisal
score, 95% CI = 1.1 – 1.4). Finally, the Constant Low (CL)
Quality of Life class was differentiated by female gender
(adjusted OR = 2.09, 95% CI = 1.1 – 3.8), younger age
(adjusted OR = 1.74, 95% CI = 1.3 – 2.4), late disease stage
(adjusted OR = 2.13, 95% CI = 1.1 – 4.2), poor social sup-
port (adjusted OR = 2.32, 95% CI = 1.6 – 3.3), a more
negative cognitive appraisal (adjusted OR = 1.77 per unit
Figure 1 Estimated mean trajectories of SWLS (four-class model
with 5 covariates, N = 1615).
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decrease in the appraisal score, 95% CI = 1.6 – 2.0), and
low optimism (adjusted OR = 1.27 per unit decrease in the
optimism score, 95% CI = 1.2 – 1.4).
Trajectory classes based on five FACT-C subscales
Distinct classes of trajectory patterns for FACT-C GP, GS,
GE, GF and C subscales were identified using GMM.
Predictors that significantly differentiated the trajectory
classes were also found to be different between the five
FACT-C subscales. In Table 3, we present the adjusted
ORs of significant predictors for comparing the constant
low (CL) or low decrease (LD) classes relative to the
constant high (CH) class, with the five subscales. The CL
and CH trajectories have a constantly low and high score
throughout the follow-up period, respectively. The LD
trajectory decreases from an early low start.
We found that poor social support, lower cognitive ap-
praisal and optimism significantly increased the chance
of lower scores in all Quality of Life FACT-C subscales
(except the GP subscale for social support). Gender
significantly differentiated the CL/LD class from the CH
class for the FACT-C GS, GF and C subscales, while a
younger age significantly increased the chance of lower
scores in GS and GE subscales. Late disease stage also
increased the chance of belonging to the CL/LD class,
compared to the CH class, for the GP, GE and GF sub-
scales. The C subscale appears to be distinct among the
five FACT-C subscales, because there were two unique
predictors (socioeconomic disadvantage and remoteness
of residence) that significantly differentiated the CL/LD
class from the CH class.
Discussion
Three quarters of all CRC survivors experienced consist-
ently medium to high HR-QOL for the five years after
their cancer diagnosis; and one in five had consistently
poorer outcomes with a smaller group declining in HR-
QOL at three years. Hence, it appears that while many
CRC survivors do well over time, a sizeable subgroup
carry a substantive long term health burden. Character-
istics that placed individuals at risk of these negative
outcomes were clear: poorer psychological resources
predicted a more negative long term trajectory of QOL
for CRC survivors. This was the case for the person’s
subjective judgment of their QOL, as well as their
HR-QOL; and suggests that in order to improve these
outcomes, interventions early in the illness experience to
improve these resources are needed. In this context,
interventions based on social cognitive theory may be
most salient [31]. Therapy targets here include self-efficacy
[32], outcome expectations [33], and self-regulation [32],
with meta-analyses suggesting strategies that target these
components are associated with better outcomes [31].
Support interventions that promote optimism and hope in
a supportive group or dyadic peer setting may also be indi-
cated, where peer interaction acts as the mechanism for
Table 1 Predictors of SWLS trajectory class membership (N = 1615)
Predictor Adjusted OR (95% CI) relative to constant high p-valuec
Medium decrease Medium increase Constant low
Age (Youngera) 1.22 (1.0, 1.5) 1.25* (1.0, 1.6) 2.01* (1.5, 2.8) < 0.001
Education level 0.010
Less than 8 years 1.04 (0.6, 1.9) 0.37* (0.2, 0.9) 0.26 (0.1, 2.2)
8 – 12 years or College Reference Reference Reference
University 0.76 (0.4, 1.4) 0.60 (0.3, 1.1) 0.42 (0.1, 1.2)
Social support (Dissatifiedb) 1.44* (1.1, 1.8) 1.62* (1.3, 2.0) 1.89* (1.4, 2.5) < 0.001
Low cancer threat appraisal 1.14* (1.1, 1.2) 1.16* (1.1, 1.2) 1.40* (1.3, 1.5) < 0.001
Low optimism 1.11* (1.1, 1.2) 1.19* (1.1, 1.3) 1.31* (1.2, 1.4) < 0.001
* significant at 0.05 level on the adjusted log odds of being in the class versus the Constant High class.
a patient age is categorized into “20-49”, “50-59”, “60-69”, “70-80” (treated as ordinal in GMMs).
b satisfaction with social support received (ordinal scale from 0 “very dissatisfied” to 5 “very satisfied”).
c likelihood ratio test (full model versus model without the predictor under consideration).
Figure 2 Estimated mean trajectories of FACT-C (four-class
model with 6 covariates, N = 1618).
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change through the processes of social comparison and so-
cial support [34].
Younger age was confirmed also as a risk factor for
poorer QOL outcomes, a finding that is consistent with
other cancer types and likely related to life stage de-
mands and expectations [35,36]. Specifically, younger
CRC survivors may still be building careers and families,
have greater financial responsibilities, and also see their
cancer as occurring out of age-related usual expectations
for health and illness events. A novel finding was that re-
moteness of residence and socioeconomic disadvantage
uniquely predicted poorer outcomes for the colorectal
specific quality of life domain that reflects disease-specific
iatrogenic effects. This seems consistent with findings that
increasing remoteness of residence and area-based social
disadvantage are independently associated with lower
colorectal cancer survival [37]. The reasons for this are
unclear, however, evidence that patients living outside
major cities have a higher risk of advanced colorectal can-
cer at diagnosis[38] and also that survival decreases with
increasing distance to the patient’s closest radiotherapy
treatment facility [39] suggest that differential access to
diagnostic and treatment services are possible factors.
Hence, these patients may experience greater disease
Table 2 Predictors of FACT-C trajectory class membership (N = 1618)
Predictor Adjusted OR (95% CI) relative to constant high (CH) class p-valuec
Constant medium Medium decrease Constant low
Sex (Male) 0.76 (0.5, 1.1) 1.55 (0.7, 3.6) 0.48* (0.3, 0.9) 0.024
Age (Youngera) 0.99 (0.8, 1.3) 1.22 (0.8, 1.9) 1.74* (1.3, 2.4) < 0.001
Disease stage 0.002
Stages 0, I, II Reference Reference Reference
Stages III, IV 1.26 (0.8, 2.0) 3.46* (1.7, 7.1) 2.13* (1.1, 4.2)
Unknown 0.74 (0.4, 1.4) 1.21 (0.4, 3.4) 0.69 (0.3, 1.6)
Social support (Dissatifiedb) 1.42* (1.0, 2.0) 1.14 (0.7, 1.9) 2.32* (1.6, 3.3) < 0.001
Low cancer threat appraisal 1.27* (1.2, 1.4) 1.24* (1.1, 1.4) 1.77* (1.6, 2.0) < 0.001
Low optimism 1.10* (1.0, 1.2) 1.06 (1.0, 1.1) 1.27* (1.2, 1.4) < 0.001
* significant at 0.05 level on the adjusted log odds of being in the class versus the Constant High class.
a patient age is categorized into “20-49”, “50-59”, “60-69”, “70-80” (treated as ordinal in GMMs).
b satisfaction with social support received (ordinal scale from 0 “very dissatisfied” to 5 “very satisfied”).
c likelihood ratio test (full model versus model without the predictor under consideration).
Table 3 Predictors of CL trajectory class for various FACT-C sub domains (N = 1618)
Predictor Adjusted OR (95% CI) for constant low (CL) class relative to constant high (CH) class
Physical Social/Family Emotional wellbeing Functional Colorectal cancer specific
Sex (Male) 3.52* (1.9, 6.4) 0.39* (0.2, 0.8) 0.23* (0.1, 0.4)
Age (Youngera) 1.48* (1.1, 2.1) 1.89* (1.3, 2.7)
Socioeconomic Disadv. 1.37* (1.1, 1.8)
Disease stage
Stages 0, I, II Reference Reference Reference
Stages III, IV 2.61* (1.7, 3.9) 2.20* (1.2, 3.9) 2.97* (1.5, 5.9)
Unknown
Remoteness of residence
Major city 0.42* (0.2, 0.9)
Inner regional Reference
Outer regional
Remote/very remote
Social support (Dissatifiedb) 7.83* (3.7, 16) 1.29* (1.0, 1.6) 1.95* (1.3, 2.9) 1.51* (1.2, 2.0)
Low cancer threat appraisal 1.09* (1.0, 1.2) 1.19* (1.1, 1.3) 1.29* (1.1, 1.5) 1.79* (1.5, 2.1) 1.37* (1.2, 1.5)
Low optimism 1.06* (1.0, 1.1) 1.26* (1.2, 1.4) 1.22* (1.1, 1.3) 1.26* (1.1, 1.5) 1.14* (1.1, 1.2)
* shown only significant results at 0.05 level on the adjusted log odds of being in the CL class versus the CH class.
a patient age is categorized into “20-49”, “50-59”, “60-69”, “70-80” (treated as ordinal in GMMs).
b satisfaction with social support received (ordinal scale from 0 “very dissatisfied” to 5 “very satisfied”).
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burden as a result of poorer access to optimal medical
treatment.
While the patterns for prediction for life satisfaction
were similar to that for HR-QOL, there were some sub-
stantive differences. First, almost half of all participants
reported constant high life satisfaction. Specifically, for
these individuals the experience of having cancer did not
lead them to judge their lives globally as being impaired
or less than ideal, based on their own values or internal
standards. For those participants whose life satisfaction
trajectories varied over time (both declining and increas-
ing) they seemed to return largely to their baseline state
at five years. This suggests two conclusions. First, that
while life satisfaction may respond to external events
changes (such as a cancer diagnosis), it is a temporally
stable phenomenon [40]. This finding adds to the body of
knowledge about our understanding of life satisfaction as
a construct. Second, this may also speak to individuals’ re-
silience to cancer. Resilience is broadly conceptualized as
the ability to sustain trauma without developing reactive
psychopathology [41]. Previous research comparing can-
cer survivors to an age, gender and education matched
sample, concluded that while survivors do experience im-
paired psychological functioning in some domains, such
as social wellbeing, they are resilient [42]. The ability of
cancer survivors to maintain a stable sense of life satisfac-
tion after their cancer experience may also, at least in part,
reflect resilience.
In this regard, a limitation of the present study is that
we did not specifically measure resilience such that our
picture of what factors matters most in predicting qual-
ity of life outcomes may be incomplete. This is an area
for future research. As well, although we were able to re-
cruit a substantive study sample it is possible that those
who did not participate varied in important ways, for
example may have been more distressed or less health
literate. As we did not have data on non-respondents we
were unable to assess this. However, key strengths of this
study include the prospective design with long term fol-
low up, application of well validated and reliable mea-
sures, and a large population based sample.
In conclusion, the present results add to the growing
body of knowledge about the heterogeneous nature of
individual adjustment after cancer and further highlight
the importance of considering inter-individual differences
in research with this population group, as well as in plan-
ning service delivery. The contrast between trajectory pat-
terns for HR-QOL and life satisfaction suggests that they
are distinct adjustment outcomes. Life satisfaction appears
in this population group to be temporally stable and this
may reflect individuals’ psychological resilience to the ex-
perience of cancer. There is growing recognition of the
importance of patient-focused outcomes in cancer care
[43]; where the quality of a person’s life and the personal
preferences and values of that person guide their health
care. The inclusion of life satisfaction in future research as
a distinct adjustment outcome based on the individual’s
point of reference is warranted.
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